HANOI -- Vietnam is set to benefit from a flood of capital from European investors, led by companies based in the U.K. and France, as they vie for opportunities in the Southeast Asian country in the face of the COVID-19 pandemic.
Standard Chartered, Sanofi and AstraZeneca scramble to gain foothold

A girl receives a Pfizer COVID-19 vaccine in Ho Chi Minh City on Oct. 27: Vietnam has received a string of investment commitments from drugmakers to increase production in the country. © VNA via AP
HANOI -- Vietnam is set to benefit from a flood of capital from European investors, led by companies based in the U.K. and France, as they vie for opportunities in the Southeast Asian country in the face of the COVID-19 pandemic.